Emily E. Lyons

949 total citations · 1 hit paper
7 papers, 582 citations indexed

About

Emily E. Lyons is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emily E. Lyons has authored 7 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emily E. Lyons's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Renal cell carcinoma treatment (4 papers). Emily E. Lyons is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Renal cell carcinoma treatment (4 papers). Emily E. Lyons collaborates with scholars based in United States. Emily E. Lyons's co-authors include Michael J. Pishvaian, Edik M. Blais, Andrew Hendifar, Subha Madhavan, Lynn M. Matrisian, Jonathan R. Brody, Vincent Chung, Lola Rahib, Emanuel F. Petricoin and Davendra Sohal and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Emily E. Lyons

6 papers receiving 578 citations

Hit Papers

Overall survival in patients with pancreatic cancer recei... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily E. Lyons United States 6 511 386 147 132 74 7 582
Patricia DeArbeloa United States 4 326 0.6× 261 0.7× 103 0.7× 93 0.7× 60 0.8× 9 411
Ming Yao China 12 287 0.6× 156 0.4× 155 1.1× 217 1.6× 128 1.7× 35 481
Céline Gavoille France 8 234 0.5× 174 0.5× 91 0.6× 106 0.8× 42 0.6× 27 344
Etienne Rouleau France 11 303 0.6× 291 0.8× 131 0.9× 219 1.7× 55 0.7× 39 547
Alexander G. Raufi United States 11 275 0.5× 125 0.3× 156 1.1× 140 1.1× 111 1.5× 36 457
Ruoyu Shi China 5 256 0.5× 201 0.5× 142 1.0× 67 0.5× 86 1.2× 15 473
Maria Popoli United States 5 286 0.6× 358 0.9× 178 1.2× 129 1.0× 77 1.0× 13 577
Smruthy Sivakumar United States 14 232 0.5× 209 0.5× 251 1.7× 234 1.8× 26 0.4× 43 543
Israel Cañadas Spain 9 289 0.6× 109 0.3× 183 1.2× 211 1.6× 43 0.6× 11 487

Countries citing papers authored by Emily E. Lyons

Since Specialization
Citations

This map shows the geographic impact of Emily E. Lyons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily E. Lyons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily E. Lyons more than expected).

Fields of papers citing papers by Emily E. Lyons

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily E. Lyons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily E. Lyons. The network helps show where Emily E. Lyons may publish in the future.

Co-authorship network of co-authors of Emily E. Lyons

This figure shows the co-authorship network connecting the top 25 collaborators of Emily E. Lyons. A scholar is included among the top collaborators of Emily E. Lyons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily E. Lyons. Emily E. Lyons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hendifar, Andrew, Edik M. Blais, Brian M. Wolpin, et al.. (2021). Retrospective Case Series Analysis ofRAFFamily Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies. JCO Precision Oncology. 5(5). 1325–1338. 22 indexed citations
2.
Pishvaian, Michael J., Edik M. Blais, Jonathan R. Brody, et al.. (2020). Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. The Lancet Oncology. 21(4). 508–518. 327 indexed citations breakdown →
3.
Hendifar, Andrew, Edik M. Blais, Dzung Thach, et al.. (2020). Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.. Journal of Clinical Oncology. 38(15_suppl). 4641–4641. 7 indexed citations
4.
Matrisian, Lynn M., Edik M. Blais, Emily E. Lyons, et al.. (2019). Precision Oncology for Pancreatic Cancer across the United States: the Know Your Tumor ® experience. Annals of Oncology. 30. vi30–vi30.
5.
Pishvaian, Michael J., Edik M. Blais, Jonathan R. Brody, et al.. (2019). Outcomes in pancreatic adenocarcinoma (PDA) patients (pts) with genetic alterations in DNA damage repair (DDR) pathways: Results from the Know Your Tumor (KYT) program.. Journal of Clinical Oncology. 37(4_suppl). 191–191. 17 indexed citations
6.
Pishvaian, Michael J., Edik M. Blais, Jonathan R. Brody, et al.. (2019). Outcomes in Patients With Pancreatic Adenocarcinoma With Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program. JCO Precision Oncology. 3(3). 1–10. 60 indexed citations
7.
Pishvaian, Michael J., R Joseph Bender, Lola Rahib, et al.. (2018). Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. Clinical Cancer Research. 24(20). 5018–5027. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026